[
  {
    "ts": null,
    "headline": "Biogen Inc. stock underperforms Friday when compared to competitors",
    "summary": "Biogen Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2c4b8cf33f22ffa2ca48dbdb870cd9d0a2fb867801f77d9e74553628e13018fd",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738343220,
      "headline": "Biogen Inc. stock underperforms Friday when compared to competitors",
      "id": 132534953,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2c4b8cf33f22ffa2ca48dbdb870cd9d0a2fb867801f77d9e74553628e13018fd"
    }
  },
  {
    "ts": null,
    "headline": "Biogen, Eisai : EC Asks CHMP to Take Another Look at Leqembi",
    "summary": "By Colin Kellaher Biogen and Eisai have hit another bump in their quest to win European regulatory approval of their Alzheimer's drug Leqembi. The companies on Friday said the European...",
    "url": "https://finnhub.io/api/news?id=a0ad8335447271826b5dcfc3a3b756e34dbfee705c861cb2927e624b6e09d62b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738308637,
      "headline": "Biogen, Eisai : EC Asks CHMP to Take Another Look at Leqembi",
      "id": 132504341,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Biogen and Eisai have hit another bump in their quest to win European regulatory approval of their Alzheimer's drug Leqembi. The companies on Friday said the European...",
      "url": "https://finnhub.io/api/news?id=a0ad8335447271826b5dcfc3a3b756e34dbfee705c861cb2927e624b6e09d62b"
    }
  },
  {
    "ts": null,
    "headline": "Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi",
    "summary": "Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi",
    "url": "https://finnhub.io/api/news?id=9a2ba48d0d9614920393fab5480e1f4ffdc1cc1312bab8d6b6f387f25ef77711",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738307640,
      "headline": "Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi",
      "id": 132534954,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi",
      "url": "https://finnhub.io/api/news?id=9a2ba48d0d9614920393fab5480e1f4ffdc1cc1312bab8d6b6f387f25ef77711"
    }
  },
  {
    "ts": null,
    "headline": "Europe to review safety data for Eisai-Biogen Alzheimer's drug",
    "summary": "The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's Alzheimer's drug Leqembi, the agency said on Friday. The safety...",
    "url": "https://finnhub.io/api/news?id=25be6f3ff452a4f919263352b4ebc3f3420fa75955bf6764b6394a1b4ba101e1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738305965,
      "headline": "Europe to review safety data for Eisai-Biogen Alzheimer's drug",
      "id": 132504094,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's Alzheimer's drug Leqembi, the agency said on Friday. The safety...",
      "url": "https://finnhub.io/api/news?id=25be6f3ff452a4f919263352b4ebc3f3420fa75955bf6764b6394a1b4ba101e1"
    }
  },
  {
    "ts": null,
    "headline": "Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union",
    "summary": "TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 -- Eisai Co., Ltd. and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as...",
    "url": "https://finnhub.io/api/news?id=16337370353012a609428accee101e02c9700d6be142ce7a8632e288ec4aad7f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738305064,
      "headline": "Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union",
      "id": 132503998,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 -- Eisai Co., Ltd. and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as...",
      "url": "https://finnhub.io/api/news?id=16337370353012a609428accee101e02c9700d6be142ce7a8632e288ec4aad7f"
    }
  }
]